This Government Contract opportunity from Department Of Veterans Affairs was posted on January 18, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
6505-- Escitalopram Tablets Effective 3/17/24 - 3/16/25
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract, identified by solicitation number 36E79723R0025 and award number 36E79724D0014, was issued by the Department of Veterans Affairs through Nac Pharmaceuticals in Hines, Illinois. The agreement was awarded to Exelan Pharmaceuticals Inc on January 17, 2024, for the procurement of Escitalopram Tablets. The total award value is $48,442,917.75, with a performance period effective from March 17, 2024, through March 16, 2025. The procurement process included an amendment to extend the closing date to October 3, 2023, at 2:30 PM Central Time. The contract falls under NAICS code 325412 and was managed by Contract Specialist Billy Fong.
General Info
Contract Value
$0Place of Performance
IL, USASet-Aside
Awardee
EXELAN PHARMACEUTICALS INCAward Issued Date
Documents
1AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
